Φορτώνει......
Metformin Inhibits Gluconeogenesis by a Redox-Dependent Mechanism In Vivo
Metformin, the universal first-line treatment for type 2 diabetes, exerts its therapeutic glucose-lowering effects by inhibiting hepatic gluconeogenesis. However, the primary molecular mechanism of this biguanide remains unresolved, though it has been suggested to act, at least partially, by mitocho...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Nat Med |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6129196/ https://ncbi.nlm.nih.gov/pubmed/30038219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41591-018-0125-4 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|